Italia markets closed

Ipca Laboratories Limited (IPCALAB.NS)

NSE - NSE Prezzo in tempo reale. Valuta in INR.
Aggiungi a watchlist
1.181,35-18,45 (-1,54%)
Alla chiusura: 03:30PM IST

Ipca Laboratories Limited

48, Kandivli Industrial Estate
Kandivli (West)
Mumbai 400067
India
91 22 6647 4444
https://www.ipca.com

Settore/iHealthcare
SettoreDrug Manufacturers - Specialty & Generic
Impiegati a tempo pieno

Figure dirigenziali chiave

NomeTitoloRetribuzioneEsercitateAnno di nascita
Mr. Premchand Godha A.C. A., B. Com., CAExecutive Chairman112,65MN/D1946
Mr. Pranay Premchand GodhaCEO, MD & Executive Director50,98MN/D1972
Mr. Ajit Kumar Bhanwarlal Jain A.C.A., B.Sc.CFO, MD & Executive Director77,54MN/D1955
Mr. Harish P. KamathCompliance Officer, Corporate Counsel & Company SecretaryN/DN/D1959
Mr. Prashant Premchand GodhaExecutive Director46MN/D1975
Mr. Pawan KothariVice President of OperationsN/DN/D1965
Mr. Vishnu Saran Singh KushwahaVice President of TechnicalN/DN/D1968
Mr. Sunil GhaiPresident of MarketingN/DN/D1963
Mr. Sameer S. TamhaneSenior Vice President of Human ResourcesN/DN/D1967
Dr. Ashok KumarPresident of R&D - ChemicalsN/DN/D1954
Gli importi risalgono al giorno 31 dicembre 2023 e i valori di compensazione riguardano l'anno fiscale che si chiude a tale data. La retribuzione include salari, bonus ecc. "Esercitate" è il valore delle opzioni esercitate durante l'anno fiscale. Valuta in INR.

Descrizione

Ipca Laboratories Limited, a pharmaceutical company, manufactures and markets pharmaceutical formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India. It offers APIs in therapeutic areas of anti-hypertensive, anti-malarial, diuretic, DMARD, and anthelmintic. The company provides generic and branded formulations in the therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetology, dermatology, gastroenterology, hematology, neurology, ophthalmology, rheumatology, and urology, as well as psychiatry, probiotics, respiratory, orthopedics, oral anti diabetes drug, nutraceuticals, NSAIDs, neuropathic pain, malaria, infectious diseases, immunosuppressant, hepatoprotectives, helminthics, fever, and emollients/protectives. It also exports its products worldwide. The company was incorporated in 1949 and is based in Mumbai, India.

Governance aziendale

L'ISS Governance QualityScore di Ipca Laboratories Limited al N/D è N/D. I criteri di valutazione fondamentali sono revisione: N/D; Consiglio di Amministrazione: N/D; diritti degli azionisti: N/D; retribuzione: N/D.

Punteggi di corporate governance forniti da Institutional Shareholder Services (ISS). I punteggi indicano il rango decile relativo all’indice o alla regione. Un punteggio di decile pari a 1 indica un governance risk più basso, mentre un punteggio di 10 indica un governance risk più alto.